We would like to invite you to our upcoming webinar

“Using Microfluidic Modulation Spectroscopy to Monitor Protein Misfolds and Structural Similarity”

Date: June 27th 2018 at 11am ET for an hour.

Speakers: Brent Kendrick, VP R&D at Elion Labs & Eugene Ma, CTO at RedShiftBio

See change™ in protein characterization.


The Next Generation in Protein Characterization


The AQS3pro launches a new era in IR spectroscopy and protein characterization, bringing repeatable, high sensitivity, automated measurements to every stage of the biopharmaceutical pipeline. Powered by Microfluidic Modulation Spectroscopy (MMS), the AQS3pro measures the secondary structure of proteins over nearly four decades of concentration, from 0.1 mg/ml to over 200 mg/ml. Driven by the industry-leading AQS3delta Analytical Software package, it streamlines and simplifies 5 key measurements:

Aggregation | Quantitation | Stability | Structure | Similarity

Load samples and walk away. Generate precise, high sensitivity data. Analyze and understand protein behavior.

Latest News

Protein Society, July 24, Boston, MA

See change in your protein, in your workflow, and your efficiency.

Visit the product page to learn more.


RedShiftBio™ is an innovative provider of analytical instrumentation for the research, development and manufacturing of protein therapeutic drugs.

Read More

Learn More

MMS For Protein Therapeutic Drug Analysis

Enhanced Protein Structural Characterization using MMS

Contact Us

RedShift BioAnalytics Inc.

131 Middlesex Turnpike
Burlington, MA 01803

T: 781.345.7300
F: 781-345-7301
E: info@redshiftbio.com

RedShift™, RedShiftBio™,  See Change™, and AQS3™ are trademarks of RedShift BioAnalytics, Inc.